Michael Power Email

Chief Business Development Officer . VieCure

Current Roles

Employees:
77
Revenue:
$11.2M
About
Innovations that empower people to live their best lives. In this time of rapid change and advancement in genomic-based oncology, how do you package the very best in oncology knowledge and make it available and usable at the point of care, for every patient and provider? “One-size fits all” cancer therapies are simply not good enough. Advances in our understanding of cancer, including how alterations in genes drive cancer growth, along with the ability to test for these alterations, have dramatically changed the paradigm for cancer treatment. Patients need personalized therapies that are responsive to the molecular profiles of their tumors and individual circumstances. Our platform opens the door to new and unique care capabilities for every provider and patient with expert guidance and real-time decision support. A transformation in oncology care is right here and now. It is driven by major achievements in clinical research and technological advancements, economical access to next-generation genomic sequencing to determine the molecular profile of tumors, rapid delivery of new drugs designed to address specific genomic alterations, and the effective use of AI to provide innovative medical treatment considerations and new knowledge to care providers and patients in real time. VieCure is focused on the convergence of these technologies. Careers: https://viecure.com/careers
VieCure Address
4949 South Syracuse Street
Denver, CO
United States
VieCure Email

Past Companies

VieCureChief Business Development Officer
TbaytelMember of the Board and Past Chairman of the Board
ElektaVice President, Enterprise Solutions (Global Strategic Accounts)

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.